J. Jefferson Smith insider trades: Precision Biosciences (DTIL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where J. reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | DTIL | ↓ Sell | 4,925 | $3.84 | $19K | Direct | Feb 19, 2026 (1d) |
| Jan 21, 2026 | DTIL | ↓ Sell | 10,200 | $4.03 | $41K | Direct | Jan 22, 2026 (1d) |
| Mar 4, 2025 | DTIL | ↓ Sell | 154 | $4.91 | $756 | Direct | Mar 5, 2025 (1d) |
| Jan 22, 2025 | DTIL | ↓ Sell | 10,287 | $4.79 | $49K | Direct | Jan 22, 2025 (0d) |
| Jun 10, 2024 | DTIL | ↓ Sell | 50 | $11.79 | $590 | Direct | Jun 11, 2024 (1d) |
| May 2, 2024 | DTIL | ↓ Sell | 154 | $10.32 | $2K | Direct | May 3, 2024 (1d) |
| Jan 23, 2024 | DTIL | ↓ Sell | 28,000 | $0.37 | $10K | Direct | Jan 23, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DTIL insiders
Open-market trades in the last 12 months
About J. Jefferson Smith's insider trades
J. Jefferson Smith is Chief Research Officer at Precision Biosciences (DTIL). Since Jan 23, 2024, J. has reported no open-market purchases and 7 sales worth $123K on SEC Form 4. In the last 12 months: 2 sales ($60K).
Their filings also include grants and awards (9 filings), option exercises (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DTIL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.